The Splicing History of an mRNA Affects Its Level of Translation and Sensitivity to Cleavage by the Virion Host Shutoff Endonuclease during Herpes Simplex Virus Infections.
During lytic herpes simplex virus (HSV) infections, the virion host shutoff (Vhs) (UL41) endoribonuclease degrades many cellular and viral mRNAs. In uninfected cells, spliced mRNAs emerge into the cytoplasm bound by exon junction complexes (EJCs) and are translated several times more efficiently than unspliced mRNAs that have the same sequence but lack EJCs. Notably, most cellular mRNAs are spliced, whereas most HSV mRNAs are not. To examine the effect of splicing on gene expression during HSV infection, cells were transfected with plasmids harboring an unspliced renilla luciferase (RLuc) reporter mRNA or RLuc constructs with introns near the 5' or 3' end of the gene. After splicing of intron-containing transcripts, all three RLuc mRNAs had the same primary sequence. Upon infection in the presence of actinomycin D, spliced mRNAs were much less sensitive to degradation by copies of Vhs from infecting virions than were unspliced mRNAs. During productive infections (in the absence of drugs), RLuc was expressed at substantially higher levels from spliced than from unspliced mRNAs. Interestingly, the stimulatory effect of splicing on RLuc expression was significantly greater in infected than in uninfected cells. The translational stimulatory effect of an intron during HSV-1 infections could be replicated by artificially tethering various EJC components to an unspliced RLuc transcript. Thus, the splicing history of an mRNA, and the consequent presence or absence of EJCs, affects its level of translation and sensitivity to Vhs cleavage during lytic HSV infections.


OBJECTIVE
Most mammalian mRNAs are spliced. In contrast, of the more than 80 mRNAs harbored by herpes simplex virus 1 (HSV-1), only 5 are spliced. In addition, synthesis of the immediate early protein ICP27 causes partial inhibition of pre-mRNA splicing, with the resultant accumulation of both spliced and unspliced versions of some mRNAs in the cytoplasm. A common perception is that HSV-1 infection necessarily inhibits the expression of spliced mRNAs. In contrast, this study demonstrates two instances in which pre-mRNA splicing actually enhances the synthesis of proteins from mRNAs during HSV-1 infections. Specifically, splicing stabilized an mRNA against degradation by copies of the Vhs endoribonuclease from infecting virions and greatly enhanced the amount of protein synthesized from spliced mRNAs at late times after infection. The data suggest that splicing, and the resultant presence of exon junction complexes on an mRNA, may play an important role in gene expression during HSV-1 infections.
Division of Cell Biology and Biophysics, School of Biological Sciences, University of Missouri-Kansas City, Kansas City, Missouri, USA.
Jouliana
J
Sadek
Division of Cell Biology and Biophysics, School of Biological Sciences, University of Missouri-Kansas City, Kansas City, Missouri, USA readgs@umkc.edu.
G Sullivan
GS
Read
D000818:Animals; D002522:Chlorocebus aethiops; D005091:Exons; D006367:HeLa Cells; D018259:Herpesvirus 1, Human / Q000235:genetics* / Q000472:pathogenicity* / Q000502:physiology; D006801:Humans; D014176:Protein Biosynthesis; D012326:RNA Splicing; D020871:RNA Stability; D012333:RNA, Messenger / Q000235:genetics* / Q000378:metabolism*; D012367:RNA, Viral / Q000235:genetics* / Q000378:metabolism*; D012260:Ribonucleases / Q000235:genetics* / Q000378:metabolism*; D014709:Vero Cells; D014764:Viral Proteins / Q000235:genetics* / Q000378:metabolism*; D014771:Virion / Q000235:genetics / Q000472:pathogenicity / Q000502:physiology
D012333:RNA, Messenger; D012367:RNA, Viral; D014764:Viral Proteins; C070722:virion host shutoff protein, Simplexvirus; D012260:Ribonucleases
J Virol. 2014 Sep 1;88(17):9624-32
24920814
J Virol. 1999 Nov;73(11):9117-29
10516018
J Biol Chem. 2001 Aug 17;276(33):30914-22
11418588
J Virol. 1989 May;63(5):1897-906
2539493
J Virol. 2011 Jun;85(11):5363-73
21430045
EMBO J. 2003 Apr 1;22(7):1608-19
12660167
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3603-8
14993598
J Virol. 2016 Jun 10;90(13):6049-57
27099317
Prog Nucleic Acid Res Mol Biol. 2002;72:307-31
12206455
Wiley Interdiscip Rev RNA. 2013 Nov-Dec;4(6):693-708
23900973
RNA. 2003 May;9(5):607-17
12702819
J Virol. 2003 Sep;77(17):9337-45
12915549
J Virol. 1994 Aug;68(8):4797-810
8035480
J Virol. 2002 Dec;76(24):12877-89
12438613
J Virol. 1994 Dec;68(12):7790-9
7966568
Cell. 2008 Apr 18;133(2):213-6
18423193
J Virol. 2002 Mar;76(5):2054-61
11836383
J Virol. 1991 Jan;65(1):112-22
1845879
Nat Struct Mol Biol. 2004 Apr;11(4):346-51
15034551
J Virol. 1996 Aug;70(8):5665-7
8764085
J Virol. 1995 Oct;69(10):6063-76
7666511
Cell. 2009 May 1;137(3):536-48
19410547
J Virol. 2010 Jun;84(12):6041-9
20357089
Genes Dev. 2009 Nov 1;23(21):2537-50
19884259
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11327-32
12972633
Genes Dev. 2000 May 1;14(9):1098-108
10809668
J Virol. 2004 Apr;78(7):3489-501
15016872
J Virol. 2000 Apr;74(8):3598-604
10729135
RNA. 2004 Feb;10(2):200-9
14730019
J Virol. 2008 Aug;82(15):7443-55
18495765
J Virol. 2008 Jul;82(13):6600-9
18448541
RNA. 2003 May;9(5):618-30
12702820
J Virol. 2004 Feb;78(3):1063-8
14722261
PLoS One. 2010 Feb 18;5(2):e8684
20174621
Curr Protoc Mol Biol. 2006 Feb;Chapter 15:Unit 15.8
18265376
Front Biosci. 2008 May 01;13:5241-56
18508584
J Virol. 1987 Jul;61(7):2198-207
3035220
Science. 2001 Sep 7;293(5536):1836-9
11546874
J Virol. 2001 May;75(9):4376-85
11287586
J Virol. 1999 Sep;73(9):7153-64
10438802
J Virol. 1999 Oct;73(10 ):8245-55
10482575
Mol Cell. 2000 Sep;6(3):673-82
11030346
J Gen Virol. 1984 Jul;65 ( Pt 7):1225-8
6086815
J Virol. 2008 Jun;82(11):5527-35
18367525
J Virol. 1988 Mar;62(3):912-21
2828686
J Biol Chem. 1998 Mar 27;273(13):7579-87
9516461
J Biol Chem. 1999 Dec 10;274(50):35415-24
10585411
J Virol. 1997 Dec;71(12):9188-97
9371577
J Virol. 2004 Aug;78(16):8582-92
15280467
Nat Rev Mol Cell Biol. 2011 Apr;12(4):235-45
21427765
J Virol. 1997 Oct;71(10):7157-66
9311788
J Virol. 2013 Jan;87(1):94-109
23077305
J Biol Chem. 1999 Apr 30;274(18):12236-44
10212190
J Gen Virol. 1992 Feb;73 ( Pt 2):467-70
1311370
EMBO J. 2000 Dec 15;19(24):6860-9
11118221
EMBO J. 1998 Apr 1;17(7):2107-21
9524132
J Virol. 2006 Oct;80(19):9720-9
16973576
J Biol Chem. 2001 Apr 20;276(16):12598-608
11278350
J Gen Virol. 1990 Feb;71 ( Pt 2):411-8
2155295
J Virol. 2012 Jul;86(14):7692-5
22553331
EMBO J. 2001 Sep 3;20(17):4987-97
11532962
Cell. 2012 Nov 9;151(4):750-64
23084401
Cell. 2008 Apr 18;133(2):303-13
18423201
PLoS One. 2008 Feb 13;3(2):e1583
18270573
Curr Biol. 2002 Jul 9;12(13):1060-7
12121612
EMBO J. 1996 May 15;15(10):2575-81
8665865
Proc Natl Acad Sci U S A. 1987 Apr;84(7):1926-30
3031658
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2827-32
16477041
J Virol. 2008 Apr;82(7):3642-53
18234805
J Virol. 2010 Jul;84(13):6886-90
20427534
J Virol. 2007 Feb;81(3):1148-61
17093196
J Virol. 1987 Feb;61(2):604-6
3027388
Genes Dev. 2004 Mar 15;18(6):660-72
15075293
J Virol. 1985 Sep;55(3):601-10
4020960
J Virol. 2011 Dec;85(23):12662-72
21937652
J Virol. 1993 Dec;67(12):7149-60
8230437
Curr Opin Cell Biol. 2004 Jun;16(3):279-84
15145352
J Virol. 2012 Sep;86(18):10093-102
22787211
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5903-8
23530232
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12062-7
10518576
Nat Struct Mol Biol. 2007 Dec;14(12):1173-9
18026120
J Virol. 2014 Nov;88(21):12727-39
25142597
J Virol. 2002 Sep;76(17):8560-71
12163576
J Mol Biol. 2006 Jul 21;360(4):743-9
16797590
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18165-70
15596716
J Virol. 2006 Sep;80(18):9341-5
16940547
J Virol. 1983 May;46(2):498-512
6302315
Nucleic Acids Res. 1994 Dec 11;22(24):5255-64
7816614
Genes Dev. 2004 Jan 15;18(2):210-22
14752011
Virology. 2002 Mar 1;294(1):189-98
11886277
J Virol. 2005 Apr;79(7):4090-8
15767410
J Virol. 2013 Mar;87(6):3271-6
23302873
J Virol. 2005 Aug;79(15):9651-64
16014927
Cell. 2000 Dec 22;103(7):1121-31
11163187
J Virol. 1995 Nov;69(11):6779-86
7474089
J Virol. 2001 Nov;75(21):10272-80
11581395
EMBO J. 2001 Apr 17;20(8):2062-8
11296238